Weiss Multi-Strategy Advisers’s Regenxbio RGNX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-200,000	Closed	-$3.95M	–	596
2017 Q2	$3.95M	Sell	200,000 -205,204	-51%	-$3.97M	0.17%	184
2017 Q1	$7.82M	Buy	405,204 +80,000	+25%	+$1.54M	0.31%	88
2016 Q4	$6.03M	Buy	325,204 +20,204	+7%	+$386K	0.29%	78
2016 Q3	$4.27M	Sell	305,000 -22,559	-7%	-$249K	0.26%	133
2016 Q2	$2.62M	Sell	327,559 -17,441	-5%	-$194K	0.2%	155
2016 Q1	$3.73M	Buy	345,000 +8,526	+3%	+$109K	0.16%	178
2015 Q4	$5.58M	Buy	336,474 +62,500	+23%	+$1.24M	0.38%	61
2015 Q3	$6.04M	Buy	+273,974	New	+$6.99M	0.27%	81

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RGNX Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of Regenxbio (RGNX) in Q3 2017, closing a stake of 200,000 shares — an estimated $3.95M sold.

Weiss Multi-Strategy Advisers first reported a position in RGNX in Q3 2015 and held it in 8 quarters. The position peaked at $7.82M in Q1 2017. 89 funds tracked by Wall St. Rank hold RGNX as of Q3 2017.

Weiss Multi-Strategy Advisers reported no remaining Regenxbio position as of Q3 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 200,000 Regenxbio shares in Q3 2017, an estimated $3.95M.
Weiss Multi-Strategy Advisers first reported a position in Regenxbio in Q3 2015 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Regenxbio position peaked at $7.82M in Q1 2017.
89 funds tracked by Wall St. Rank held Regenxbio as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.